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Abstract. Chronic serum sickness was induced in four
groups of Wistar rats by immunization with BSA,
cationized BSA (cBSA), human IgG (HulgG), or
human IgM (HulgM), followed by repeated intraperi-
toneal (i.p.) injection of the antigen used, to study the
effect of the characteristics of an antigen on renal
immunopathology. Renal tissue sampled 2, 4, 7, and 9
weeks after the start of the i.p. injections was examined
by light-, immunofluorescence-, and electron-
microscopy. Proteinuria was measured in urine col-
lected over 24 h. All animals given BSA, cBSA, or
HulgG developed progressive renal disease character-
ized by initial deposition of antigen and rat Ig in the
mesangium of rats given BSA or HulgG, and minimal
amounts in those given cBSA, followed by the appear-
ance in the first instance of subendothelial deposits in
the animals receiving BSA or HulgG, and later subepi-
thelial deposits in those given BSA, cBSA, or HulgG.
The appearance of immunoglobulin deposits along the
glomerular capillary wall was associated with the onset
of massive proteinuria reaching average levels of
450 mg/24 h for rats given BSA or cBSA, and
500 mg/24 h for those given HulgG. Animals injected
with HulgM showed only mesangial deposits of human
IgM and rat Ig without the development of proteinuria.
Under light-microscopy, rats given BSA, cBSA, or
HulgM showed minimal abnormalities, whereas those
receiving HulgG showed transient but severe influx of
granulocytes in glomeruli with the development of
diffuse proliferative glomerulonephritis in association
with a long-lasting phase characterized by subendothel-
ially localized immune aggregates. No differences in
the degree or type of the immune response were found
either as measured by ELISA or double radial immuno-
diffusion. We conclude that the type of glomerular
immunopathology during chronic serum sickness is
partially dependent on the size of the antigen used for
induction of the disease.
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Box 9603. 2300 RC Leiden, The Netherlands.
Key words: chronic serum sickness; antigen size; ELBA
Introduction
During the last few decades, research using animal
models has yielded considerable information about the
pathogenic mechanisms underlying immunologically
mediated glomerulonephritis [1]. Originally, a patho-
genic role was established for antibodies directed to
antigens of the glomerular capillary wall (GCW) [2],
which gave rise to a linear binding of antibodies along
the GCW. Not long afterward, Germuth [3] demon-
strated an additional role for circulating immune
complexes in experimental serum sickness glomerulo-
nephritis, in this case leading to a granular binding of
IgG along the GCW. New studies began to show that
a pathogenic role played by antibodies directed against
glomerular intrinsic or planted antigens can induce
either linear or granular binding of IgG along the
GCW [4-6]. Models have recently been described in
which the binding pattern of antibodies to the glomer-
ulus can change from linear to granular in the course
of the disease. It became clear that the character of
the antigen involved was not only an important denom-
inator of the binding pattern of the antibody in the
glomerulus, but can also determine the morphology of
the glomerulonephritis it causes [7]. It was in this
context that we became interested in chronic serum
sickness as a model for human immune-mediated
kidney disease induced in rats by immunization with
and subsequent repetitive intraperitoneal injections of
a species-foreign protein [8,9]. In this model the binding
pattern of antibodies to the glomerular planted antigen
changes from a mesangial to a membranous pattern
during the course of the disease. This change has been
attributed to the height of the immune response [10],
the avidity [11-13] or precipitability of the antibodies
produced [13], or the characteristics of the antigen(s)
involved, e.g. immunogenicity and/or electrical charge
[14].
In the present study we attempted to assess the role
played by the molecular weight of the antigen in
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relation to the type of glomerulonephritis. Chronic
serum sickness was induced with three antigens
differing in molecular weight: native BSA (mol wt
66 kDa), human IgG (HulgG) (mo! wt 155 kDa), and
human IgM (HulgM) (mol wt 900 kDa). As an addi-
tional control, BSA with a neutral pi (7.4; cBSA) was
used to exclude the role of electrical charge.
Subjects and methods
Animals
Fifty 10-week-old female inbred Wistar rats weighing about
250 g each were used in this study.
Antigens
Crystalline BSA (Sigma Chemical Company, St Louis, Mo.,
USA) was used as native BSA and as a substrate for the
preparation of charge-modified BSA, neutral at physiological
pH. Crystalline HulgG was obtained from the CLB,
Amsterdam, The Netherlands. HulgM was purified from
200 ml of human myeloma serum which was first heated
(30 min; 56°C) to destroy complement activity. After this the
serum was centrifuged (10 min; 10000 g) and the supernatant
was dialysed against 0.01 M sodium acetate buffer, pH 6.0;
conductivity 1 mS at 4~C. The resulting pellet was collected
by centrifugation at 4°C for 15 min at 20 000 g, dissolved in
l M NaCl containing 2 mM EDTA and subjected to gel
nitration on a Sephacryl S-500 (Pharmacia, Woerden, The
Netherlands). The fractions containing IgM were detected
by ELISA using a monoclonal antibody (HB 57, American
Tissue Type Culture Collector, Rockville, Mo), pooled.
concentrated to 20 mg/ml, and dialysed against phosphate-
buffered saline pH 7.4 (PBS). The isoelectric point of the
commercial BSA was adjusted to pi 7.4 by cationization
induced by carbodiimide activation (EDC, Sigma Chemical
Company) of carboxyl groups and substitution by N,N-
dimethyl-l,3-propanediamine (Merck, Schuchardt, BRD)
according to Danon el at. [15]. After that, the average
isoelectric point of BSA, both charge modified and native,
and HulgG was measured in thin layers of polyacrylamide
gel containing ampholytes with a pH range of 3.5-9.5, using
an LKB flat-bed isoelectrofocusing unit (LKB Instruments
Inc., Bromma, Sweden). The isoelectric point of HulgM was
assessed by chromatofocusing. The final molecular weight of
the four antigens used was assessed by gel chromatography
on a Sephacryl S-300 column (Pharmacia Fine Chemicals
Inc., Uppsala, Sweden).
Induction of chronic serum sickness
Chronic serum sickness was induced as described elsewhere
[8]. In short, groups of 10 rats each were immunized intracut-
aneously with 1.5 mg native BSA (group I), cBSA (group II),
HulgG (group III), or HulgM (group IV), all diluted in
0.15 ml PBS and emulsified with 0.15 ml complete Freund's
adjuvant (Difco Laboratories, Detroit, Mich., USA). Forty-
two days later the animals received an intracutaneous booster
injection consisting of either 1.5 mg BSA, cBSA, HulgG, or
HulgM diluted in 0.15ml PBS, emulsified with O.I5 ml
incomplete Freund's adjuvant. Starting on day 56, 10 i.p.
injections of either 3 mg BSA, cBSA, HulgM, or 6 mg HulgG
diluted in 1 ml PBS were given over a period of 14 days,
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followed by three i.p. injections of the same solution weekly
over a period of up to 9 weeks. Ten control rats received
injections of the same vehicle but without antigen (group V).
This regimen was chosen because pilot experiments had
shown this to lead to immune complex type glomerular
disease at comparable levels and type of antigen-specific
antibodies. Administration of the antigens was stopped when
proteinuria of higher than 500 mg/24 h was reached. All
animals were killed on day 150.
Morphological studies
Small tissue specimens (0.3 mm3) for light-, immunofluores-
cence-, and electron-microscopy were taken by open biopsy
from alternate sides under ether anaesthesia on days 70, 84,
108, 122, and immediately after death. Tissue for light- and
electron-microscopy was processed as detailed previously
[16,17]. The morphological changes were evaluated independ-
ently by two microscopists. A portion of the kidney tissue
was snap-frozen in CO2 ice-cooled isopentane and stored at
-70°C until use. For the immunofluorescence studies, sections
were processed as described elsewhere [16]. Use was made of
the direct technique with goat-anti-rat IgG, rabbit-anti-rat
IgGl, lgG2a, IgG2b, or IgM, as well as goat-anti-human
IgG and IgM fiuorescein isothiocyanate (FITC) conjugated
immunoglobulins (Nordic Immunology, Tilburg, The
Netherlands) or rabbit-anti-rat complement component 3
FITC-conjugated immunoglobulins, prepared as already
described [18]. Immunofluorescence staining intensity was
scored semiquantitatively ( — to + +).
Measurement of circulating antigen-specific antibodies
For the measurement of circulating antibodies to BSA, cBSA,
HulgG, or HulgM, blood samples were collected by orbital
plexus bleeding, before immunization, on days 14, 28, 42,
56, 63, 70, 77, 84, and after that once a month until the end
of the experiments. Antibody levels were measured with an
ELISA using poiyvinylchloride ELISA plates (Titertek, Flow
Laboratories, Zwanenburg, The Netherlands) coated with
either BSA, or HulgG, or HulgM (1 ug/well) diluted in
0.1 M sodium carbonate buffer (pH 7.6) and processed as
described previously [8].
For determination of the subclass of the induced antibodies
the studies were performed with either rabbit-anti-rat poly-
valent IG, IgGl, IgG2a, IgG2b, lgG2c, or IgM (Nordic
Immunology) in the second incubation step. Titres of precip-
itable antibodies directed against the antigens used were
assessed with Mancini's double diffusion technique.
Quantitative measurement of protein excretion in the
urine
Twenty-four-hour urine was collected in metabolic cages at
three time-intervals before the experiments were started, and
on days 43, 57, 71, and after that weekly until the end of the
observation period as described previously [16].
Statistical analysis
Student's / test combined with the Scheffé procedure was
used to determine the level of significance of differences
between paired data. For the comparison of values of all
groups, variance analysis was used. P values lower than 0.05
were considered significant. All results are expressed as mean
+ standard deviation.
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Results
Experimental antigens
The molecular weight of the antigens used is given
together with their isoelectric point in Table 1.
Morphological studies
Immunofluorescence microscopy. Both native BSA-
(group I) and HulgG-induced (group III) chronic
serum sickness were associated with deposition of
antigen and rat Ig in the mesangium from day 70
onward (Figure la). This was followed in due course
by the appearance of granular deposits along the
giomerular capillary wall, observed first for rats with
BSA-induced serum sickness, but from day 84 onward
coarse granular deposits were also seen in rats given
HulgG (Figure Ib). Group II showed a mesangial
deposition pattern from day 70 on in about 40% of
the animals. On day 84 a shift toward a capillary
localization became prominent, the process bringing
about an intensely stained fine granular pattern by day
108. HulgM-induced (group IV) chronic serum sick-
ness showed mesangial deposits of HulgM and rat IgG
from days 84 and 108 respectively (Figure 2), but a
change to a localization along the glomerular capillary
wall did not occur. In all groups the antibodies depos-
ited were predominantly of the IgGl and lgG2a class,
to a lesser extent IgM, and there were only minimal
amounts IgG2b. The course of the fluorescence pat-
terns is summarized in Table 2.
Electron-microscopy. The granular staining of the
glomerular capillary wall reflected subendothelial
deposits in the early stage, and later subepithelial
electron-dense deposits, in groups I and HI.
Subendothelial immune deposits persisted longer in
group III than in group I (Figure 3). cBSA led only to
localization of electron-dense deposits in the subepi-
thelial space, mainly in the slit-pores. HulgM-induced
chronic serum sickness (group IV) exclusively showed
a mesangial localization of electron-dense material.
The results of the electron-microscopical findings are
summarized in Table 3.
Histopathology. The most prominent differences
between the experimental groups were seen in the
degree of margination of polymorphonuclear granulo-
cytes (PMNs) and monocytes, up to 12 per glomerulus
Table L Characteristics of the antigens used for the induction of
chronic serum sickness*
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Fig. 1. Imrnunoftuorescence micrographs of a glomeruius from a rat
with HulgG-tnduced serum sickness glomerulopathy. (a) Changes
in the early phase of the disease (day 70), Deposits of rat IgG are
confined to the mesangial area, (b) Changes in the membranous
phase of the disease (day 108). Granular deposits of rat IgG are
present along the glomeruiar capillary wall (Both a and b x 630)
*Molecular weight and isoelectric point of BSA, cBSA, Human
IgG, and Human IgM. The isoelectric point of the latter three is
within the same range.
Fig. 2. Immunofluorescence micrograph of a glomerulus from a rat
with HulgM-induced serum sickness glom er ulo pat hy, stained with
anti-HuIgM-FITC. Deposits of rat immunoglobulins can be seen in
the mesangial areas. ( *630)
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Fig. 3. Electron-micrograph showing the immunological damage to the GBM 100 days after HuIgG-induced experimental serum sickness.
At this time, electron-dense material is localized in both the subendothelial and the subepilhelial areas of the GBM and polymorphonuclear
cells are conspicuous. { x 8500 and x 20000)
Table 2. Combined results of immunofluorescence and electron-
microscopy
Group Day Mesangium Glomerular capillary wall
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Group I, BSA-induced serum sickness; group II, cBSA-induced
serum sickness: group III, HuIgG-induced serum sickness; group IV,
HulgM-induced serum sickness.
in rats receiving HulgG, which was detectable between
days 84 and 108 (Figure 4). An influx of granulocytes
also occurred briefly in glomeruli of rats given native
BSA, but was of a much lower level. In rats given
Fig. 4. Light-micrograph of a glornerulus from a rat suffering from
HuIgG-induced serum sickness glomerulopathy, showing marked
influx and margination of granulocytes. (PAS, x 400)
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cBSA there was no glomerular influx of PMNs either
in the mesangial area or marginated along the glomer-
ular capillary wall. Furthermore, at the end of the
experiment glomeruli of rats in group I showed signi-
ficant glomerulosclerosis, thus confirming an earlier
finding [8].
Severe glomerulosclerosis exceeding that observed in
group I with respect to number of involved glomeruli
and extent of involvement was seen at the end of the
observation period in rats with HulgG-induced serum
sickness. Throughout the observation period no signi-
ficant glomerular abnormalities were observed in the
kidneys of rats receiving HulgM, whereas group II
showed only minimal mesangial abnormalities. Finally,
the interstitial area of kidney biopsy specimens of all
the animals showed peritubular tymphocytic infiltrates,
thus confirming earlier reports [19]. The results
obtained with light-microscopy are given in Table 3.
Measurement of circulating antigen-specific antibodies
The ELISA showed a peak value of rat IgM antibodies
on day 14, followed by a slow decrease in time, but
with a sharp reduction on day 56 in groups I, II, and
III. Antigen-specific IgG2b and IgG2c concentrations
were low in all groups, the greatest concentrations
occurring around day 42, followed by a decrease after
day 56 in groups I, II, and III. Titres of IgG2a and
IgGl were high in all groups, with an initial a peak on
day 14 for both classes, rising to the highest litres of
antigen-specific IgGl on day 56 in groups I and II and
on day 70 in groups III and IV. After day 63 antigen-
specific IgG2a declined sharply in groups I, II, and III,
as did the IgGl in groups I and II.
IgGl in group III showed this reduction after day
77. Levels of IgG2a and IgGl against HulgM
decreased slowly after day 70 but large amounts were
still detectable in the circulation at the end of the
experiment. There were no significant differences in the
amounts of specific antibodies between all groups
before the sudden decline of the antibody litres in
groups I, II, and III, coinciding with the accumulation
of deposits along the glomerular capillary wall in these
groups as well as with the development of proteinuria.
Table 3. Morphological changes at the light-microscopic ieve!




















d ( + + + ) , e , f
f
a. Hypercellularity; b, mesangial expansion; c. margination of gran-
ulocytes, number of cells per glomeruius in parentheses; d, progress-
ive glomerulosclerosis ( + , + +. + + +); e, protein cast and
degradation of tubular epithelium; f, interstitial peritubular
lymphocytic infiltrates; g, minimal light-microscopic changes. Group
I, BSA-induced serum sickness; group IT, cBSA-induced serum
sickness; group III. HulgG induced serum sickness; group IV,
HulgM-induced serum sickness.
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Precipitating antibody titres directed against BSA or
HulgG, as measured by double diffusion, showed high
titres in groups I, II, and HI. Group IV tended to have
a slightly higher titre of precipitable antibodies, but
this difference was not statistically significant. A week
before the onset of pathological proteinuria in groups I,
II, and III the level of circulating precipitating antibod-
ies decreased by about 60%, thus confirming the
findings of Noble et al. in BSA-induced chronic serum
sickness [10]. The sera of the animals in group IV did
not show a significant reduclion in Ihe precipitable
antibody titres in the course of the experiments.
Quantitative measurement of protein excretion in the
urine
The course of the mean values of protein excretion in
the urine is shown in Figure 5. Animals in group I
showed proteinuria from day 63 onward, reaching a
peak of 450 mg/24 h around day 100, as seen earlier
[8]. cBSA-induced glomerulopathy gave rise to pro-
teinuria from day 91 onward, which increased up to
average levels of 450 mg/24 h. Group III showed pro-
teinuria from day 84 onward, with peak levels of on
average 500 mg/24 h on days 105-130. Throughout the
period studied, rats with HulgM-induced chronic
serum sickness showed no significant proteinuria relat-
ive to the control rats, the physiological protein excre-
tion of the control animals being lower than
15 mg/24 h.
Discussion
The study reported here has shown that the character-
istics of a planted antigen, especially its size, exert an
influence on the type of immunopathological glomer-
ular injury that evolves when an immune reaction is
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Fig. 5. Course of the mean values of protein excretion in the urine
of rats after the induction of serum sickness, calculated for groups
given BSA (I), cBSA (II), Hu-lgG (HI), or HulgM (IV). Serum
sickness glomerulopathy induced by native BSA, cBSA, or HulgG
was accompanied by the development of proteinuria. Induction of
serum sickness glomerulopathy by repeated injection of HulgM did
not lead to the development of significant proteinuria.
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antigens used, i.e. cBSA, HulgG, and HulgM, differed
in molecular weight in a range between 66kDa and
900 kDa, but had comparable isoelectric points.
Depending upon their size, the antigens induced either
a mesangial and subepithelial (cBSA, group II) or a
mesangial, subendothelial, and subepithelial (HulgG,
group III), or a strictly mesangial localization of
immune complexes (HulgM, group IV). Native BSA,
an antigen with an anionic nature, was used for studies
performed to find out whether the strict mesangial
localization in group IV (HulgM), induced by an
antigen with a slightly less cationic isoelectric point
compared to cBSA and HulgG, was influenced by
electrical charge. Native BSA (group I, pi 4.2) was in
fact quite capable of inducing immune-complex forma-
tion along the glomerular capillary wall, which excludes
a charge-dependent inability of HulgM (pi 6.5) to
localize along the glomerular capillary wall.
In chronic serum sickness, the occurrence of subepi-
thelially localized immune complexes was shown to
result from in situ formation after the combination of
antigen and antibody travelling separately across the
glomerular basement membrane [5]. As shown by
Rennke and Venkatachalam, the glomerular capillary
wall acts by selectively filtering molecules according to
their size, configuration, and electrical charge [20].
Likewise, the constituents of the immune aggregates
localized along the glomerular capillary wall in a
planted antigen model may have passed the GBM
under the same restrictions as those imposed by the
filtration properties of the glomerular capillary wall.
Molecules with a small effective radius can pass the
glomerular filter barrier easily, retention occurring
increasingly effectively with enlarging size of the molec-
ules. Molecules with a large diameter may only reach
the subepithelial region in small numbers or not at all,
since passage through the glomerular capillary wall is
hampered by the relatively small pore size particularly
of the lamina densa. This explains why in our experi-
ments the injection of relatively large molecules such
as HulgG led initially to a predominantly subendotheli-
ally localization of the deposits. Even larger molecules
such as HulgM are hardly capable of passing the
filtration barrier and therefore do not incite immune
complex formation along the glomerular capillary wall.
cBSA. a small molecule, is only retained by the filtra-
tion barrier of the slit membranes, the most passage-
restrictive barrier for molecular size [21]. For native
BSA, the rated filtration of the molecule over the
glomerular basement membrane can be reduced by its
negative electrical charge, as compared to cBSA. This
might also explain the ability of native BSA to induce
the formation of subendothelial deposits, which does
not occur when cBSA is used.
Salant et al. showed that after transplantation of
kidneys of rats previously injected with either hetero-
logous anti-GBM or anti-FxlA antibodies, which
before transplantation gave rise to a linear GBM or
subepithelial binding of the antibodies respectively, the
site of binding of heterologous antibodies directed
against renal autoantigens had a direct influence on
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the mediation and morphological expression of renal
immunopathology [22]. Studies in other autoimmune
models have also shown an influence of the localization
of the target molecule (or epitope) on renal immunopa-
thology [7,17].
Moreover, studies by Fries et at, [23], who used a
planted antigen model, showed that the disease pro-
cesses that ensued from immune-complex formation at
opposite sites of the GBM differed remarkably in their
functional and structural appearance. In our model
employing planted antigens, the type of the evolved
glomerulonephritis also depended upon the glomerular
distribution of the antigen used, because the localiz-
ation of the glomerular immune aggregates influences
chemotactic activity. The glomerular influx of PMNs
and monocytes was distinct in group III and to a lesser
extent in group I, and therefore seemed to be related
to the presence of subendothelial immune complexes.
Indeed it has been suggested that these cells are
attracted by the presence of subendothelial immune
complexes, and bind to them via their Fc-receptor [24].
In various forms of glomerulonephritis these cells are
known to have a tissue-damaging effect and may
modulate proteinuria [25-27]. In particular, monocytes
have been postulated to play a pathogenic role in
certain forms of serum sickness glomerulonephritis
[27]. In patients, intraglomerular monocyte accumula-
tion occurs [28] mainly in types of glomerulonephritis
characterized by the presence of subendothelial
immune complexes [29]. Cationic proteins released
from PMNs and platelets may interact with the anionic
structures of the GBM [30]. After this charge-
dependent interaction the deposition of antibodies in
the glomerular capillary wall may be enhanced, as has
been shown with the cationic tracer polyethyleneimine
in the Heymann model as well as in passive serum
sickness [16,31]. PMNs and monocytes may have con-
tributed by these mechanisms to the development of
proteinuria in group III, and might also have mediated
the occurrence of focal and segmental sclerosis seen
on a large scale in this group and to a lesser degree in
group I. Thus, one of the ways by which the character-
istics of a planted antigen can determine the glomerular
damage is by influencing the localization of immune
complexes, which in turn affects factors such as
chemotaxis.
Lupus nephritis, a disease for which chronic serum
sickness has been proposed as an animal model,
exhibits a range of morphological lesions as classified
by the WHO from minimal changes up to proliferative
types seen in the majority of the patients. The WHO
categories correspond with circumscript immunofluo-
rescence and electron-microscopical findings. In SLE
a multiplicity of immune reactions to cellular and
serum antigens develops, but a causative antibody
specificity or antigen has not been identified.
Recently, Schmiedeke et al. showed that histones, a
family of proteins with a strong positive charge with a
wide range of molecular weights, have a high affinity
for the glomerular basement membrane, and postulated
that they are planted autoantigens active in the patho-
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genesis of lupus nephritis [32]. Antigens with different
molecular weights may be responsible for the different
morphological presentations of the glomerular patho-
logy. Planted autoantigens with a high molecular
weight might be responsible for the mesangial immune
deposits and minimal abnormalities found light-
microscopically, for example those seen in class II
lupus nephritis. Proliferative types of glomerulo-
nephritis with subendothelial immune deposits—WHO
class III and IV—could in turn be due to intermediate
high-molecular-weight antigens, whereas in the mem-
branous form—WHO class V—an antigen of relative
low molecular weight could be responsible.
Coinciding with the development of proteinuria,
accompanied in time by the appearance of subepithelial
electron-dense deposits in groups I, II, and III, there
was a steep decline in the amount of circulating
antibodies of precipitating quality, as described else-
where [33,34], Interestingly, in patients with active SLE
the clinical manifestations of the disease have been
reported to coincide with a sharp decline in anti-
dsDNA antibodies as well [35]. Indeed, in our experi-
ments group IV, which did not show a glomerular
capillary wall localization of immune aggregates or
pathological proteinuria in the course of the disease,
did not show this decline of the antibody titre either.
The level and type of the antigen-specific immune
response were comparable in all groups, and no differ-
ences were observed in the precipitability of the evoked
antibodies. All this makes an influence of differences
in the antibody response evoked by the antigens in
question on the immunopathological features unlikely.
An important feature of two of the antigens used,
i.e. HulgG and HulgM, is that they have an antibody-
like structure. In general, during glomerulonephritis
immune complexes might be present within immune
deposits formed by specific antigenic determinants on
the IgG molecules and by anti-idiotype antibodies [36].
In this way, various antibodies with different size and
charge, acting as planted antigens, might constitute a
target for an anti-idiotypic immune response. In man,
Ig-anti-Ig complexes of the rheumatoid type have been
suggested as of nephritogenic importance in various
types of glomerular immunopathology, including lupus
nephritis, essential cryoglobulinaemia-associated neph-
ritis, and poststreptococcal glomerulonephritis.
Because of their molecular size, IgM-rheumatoid fac-
tors could be expected to localize only in the mesangial
area, whereas IgG-rheumatoid factors might occur not
only in the mesangium but also in a subendothelial
localization and, later in the course of the disease, even
subepithelially.
The characteristics of a planted antigen, including
its size, may partially account for the variety of clinical
and histopathological manifestations of planted anti-
gen-induced glomerulonephritis.
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